Clinical Evaluation of LS-03M/LS-04R for the Detection of Sentinel Lymph Node Metastasis From Breast Cancer
Observational
Observational Model: Case-Only, Time Perspective: Prospective
The study will determine the sensitivity, specificity, negative predictive value and positive predictive value of the OSNA Breast Cancer System by comparing its performance to permanent section staining.
2 years
No
United States: Food and Drug Administration
OSNA-BC-001
NCT01136369
February 2007
December 2008
Name | Location |
---|---|
Beth Israel Medical Center | New York, New York 10003 |
John Wayne Cancer Institute | Santa Monica, California 90404 |
University of Texas MD Anderson Cancer Center | Houston, Texas 77030 |
Wake Forest University Health Sciences | Winston-Salem, North Carolina 27157 |
Dallas Surgical Group | Dallas, Texas 75235 |
Washington University Medical School | St. Louis, Missouri 63110 |
WellStar Health Systems | Marietta, Georgia 30062 |
Central Carolina Surgery, PA | Greensboro, North Carolina 27401 |
Breast Care Specialist, Inc. | Westerville, Ohio 43081 |
Breast Care Specialist, PC | Allentown, Pennsylvania 18104 |
Nashville Breast Center, PC | Nashville, Tennessee 37203 |